SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-299322
Filing Date
2023-12-20
Accepted
2023-12-20 07:42:28
Documents
16
Period of Report
2023-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d624703d8k.htm   iXBRL 8-K 32380
2 EX-1.1 d624703dex11.htm EX-1.1 185045
3 EX-5.1 d624703dex51.htm EX-5.1 12376
7 GRAPHIC g624703dsp42.jpg GRAPHIC 3381
8 GRAPHIC g624703dsp43.jpg GRAPHIC 2575
  Complete submission text file 0001193125-23-299322.txt   414625

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA blue-20231219.xsd EX-101.SCH 2863
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE blue-20231219_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE blue-20231219_pre.xml EX-101.PRE 10821
10 EXTRACTED XBRL INSTANCE DOCUMENT d624703d8k_htm.xml XML 3230
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 231499385
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)